BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 33340650)

  • 1. Malignancy going viral: ACE2 and TMPRSS2 expression in conjunctival neoplastic diseases.
    Grajewski RS; Rokohl AC; Becker M; Paulsen F; Heindl LM
    Ann Anat; 2021 Mar; 234():151661. PubMed ID: 33340650
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
    Lange C; Wolf J; Auw-Haedrich C; Schlecht A; Boneva S; Lapp T; Horres R; Agostini H; Martin G; Reinhard T; Schlunck G
    J Med Virol; 2020 Oct; 92(10):2081-2086. PubMed ID: 32374427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.
    Zhou L; Xu Z; Castiglione GM; Soiberman US; Eberhart CG; Duh EJ
    Ocul Surf; 2020 Oct; 18(4):537-544. PubMed ID: 32544566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral S protein histochemistry reveals few potential SARS-CoV-2 entry sites in human ocular tissues.
    Martin G; Wolf J; Lapp T; Agostini HT; Schlunck G; Auw-Hädrich C; Lange CAK
    Sci Rep; 2021 Sep; 11(1):19140. PubMed ID: 34580409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.
    Ma D; Chen CB; Jhanji V; Xu C; Yuan XL; Liang JJ; Huang Y; Cen LP; Ng TK
    Eye (Lond); 2020 Jul; 34(7):1212-1219. PubMed ID: 32382146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A special on epidemic prevention and control: analysis on expression of 2019-nCoV related ACE2 and TMPRSS2 in eye tissues].
    Zhang BN; Wang Q; Liu T; Dou SQ; Qi X; Jiang H; Qi BX; Zhang B; Zhou QJ
    Zhonghua Yan Ke Za Zhi; 2020 Jun; 56(6):438-446. PubMed ID: 32316719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface.
    Collin J; Queen R; Zerti D; Dorgau B; Georgiou M; Djidrovski I; Hussain R; Coxhead JM; Joseph A; Rooney P; Lisgo S; Figueiredo F; Armstrong L; Lako M
    Ocul Surf; 2021 Jan; 19():190-200. PubMed ID: 32502616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors modulation on the ocular surface: A novel insight into the ocular infection and disease transmission of SARS-COV-2.
    Kaushik J; Singh A; Kochhar D; Murari T; Shetty R; Parihar JKS
    J Med Virol; 2021 May; 93(5):2614-2615. PubMed ID: 33559886
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
    Roehrich H; Yuan C; Hou JH
    Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells.
    Yao Y; Ma D; Xu Y; Yuan XL; Liang JJ; Chen SL; Jhanji V; Ng TK
    Exp Eye Res; 2022 Jan; 214():108864. PubMed ID: 34826419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
    Huang C; Jiang Y; Yan J
    J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
    Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
    Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
    J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.
    Keewan E; Beg S; Naser SA
    Front Immunol; 2021; 12():641295. PubMed ID: 34025650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of the SARS-CoV-2 entry receptors ACE2 and TMPRSS2 in healthy human conjunctiva.
    Mencucci R; Favuzza E; Becatti M; Tani A; Mazzantini C; Vignapiano R; Fiorillo C; Pellegrini-Giampietro D; Manetti M; Marini M; Landucci E
    Exp Eye Res; 2021 Apr; 205():108527. PubMed ID: 33667466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19.
    Sarver DC; Wong GW
    Biochem Biophys Res Commun; 2021 Jan; 538():92-96. PubMed ID: 33168188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
    Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
    Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer that Highly Express Both
    Wang H; Yang J
    Pathol Oncol Res; 2021; 27():612969. PubMed ID: 34257580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of SARS-CoV-2 Entry Factors' Expression in Corneal and Limbal Tissues of Adult Human Donors Aged from 58 to 85.
    Tisi A; Zerti D; Genitti G; Vicentini MT; Baccante M; Flati V; Maccarone R
    J Ocul Pharmacol Ther; 2022; 38(1):56-65. PubMed ID: 34889660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.